{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:11:41Z","timestamp":1761513101205},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.coviro.2012.02.006","type":"journal-article","created":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T08:33:41Z","timestamp":1331109221000},"page":"188-198","source":"Crossref","is-referenced-by-count":55,"title":["Reaching the last one per cent: progress and challenges in global polio eradication"],"prefix":"10.1016","volume":"2","author":[{"given":"Olen","family":"Kew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2012.02.006_bib0005","first-page":"199","article-title":"Progress towards interrupting wild poliovirus transmission worldwide: January 2010\u2013March 2011","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.coviro.2012.02.006_bib0010_1","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMp1104329","article-title":"The polio endgame","volume":"364","author":"Aylward","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2012.02.006_bib0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.pu.13.050192.001323","article-title":"Polio eradication from the Western Hemisphere","volume":"13","author":"de Quadros","year":"1992","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.coviro.2012.02.006_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.biologicals.2006.02.012","article-title":"Interrupting poliovirus transmission\u2014new solutions to an old problem","volume":"34","author":"Aylward","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.coviro.2012.02.006_bib0025","first-page":"24","article-title":"Certification of polio eradication: process and lessons learned","volume":"82","author":"Smith","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.coviro.2012.02.006_bib0030_1","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/aje\/kwq320","article-title":"From emergence to eradication: the epidemiology of poliomyelitis deconstructed","volume":"172","author":"Nathanson","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coviro.2012.02.006_bib0035","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/oxfordjournals.aje.a009924","article-title":"Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative","volume":"150","author":"Fine","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coviro.2012.02.006_bib0040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"296","author":"Kew","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.coviro.2012.02.006_bib0045_1","first-page":"846","article-title":"Update on vaccine-derived polioviruses\u2014worldwide July 2009\u2013June 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2012.02.006_bib0050","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1056\/NEJMp1005405","article-title":"The bumpy road to polio eradication","volume":"362","author":"Modlin","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2012.02.006_bib0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(11)60744-7","article-title":"The last mile in global poliomyelitis eradication","volume":"378","author":"Bhutta","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2012.02.006_bib0060_1","unstructured":"Donaldson L, El Sayed N, Koplan J, Nduati R, Toole M, de Quadros C, Mogedal S, Singhal A: Third quarterly report of the independent monitoring board of the global polio eradication initiative, October 2011. http:\/\/www.polioeradication.org\/Aboutus\/Governance\/IndependentMonitoringBoard\/Reports.aspx."},{"key":"10.1016\/j.coviro.2012.02.006_bib0065_1","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1016\/j.vaccine.2011.09.059","article-title":"Safe landing for global polio eradication: a perspective","volume":"29","author":"Arita","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2012.02.006_bib0070_1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/infdis\/jir727","article-title":"The final phase of polio eradication: new vaccines and complex choices","volume":"205","author":"Cochi","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2012.02.006_bib0075","doi-asserted-by":"crossref","first-page":"S438","DOI":"10.1093\/clinids\/6.Supplement_2.S438","article-title":"Poliomyelitis in India: prospects and problems of control","volume":"6","author":"John","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.coviro.2012.02.006_bib0080","first-page":"1523","article-title":"Progress toward poliomyelitis eradication\u2014Afghanistan and Pakistan, January 2010\u2013September 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2012.02.006_bib0085","series-title":"The Picornaviruses","first-page":"449","article-title":"The poliovirus eradication initiative","author":"Chumakov","year":"2010"},{"key":"10.1016\/j.coviro.2012.02.006_bib0090","first-page":"222","article-title":"Apparent global interruption of wild poliovirus type 2 transmission","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2012.02.006_bib0095","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(10)61230-5","article-title":"Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial","volume":"376","author":"Sutter","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2012.02.006_bib0100","first-page":"1482","article-title":"Progress toward poliomyelitis eradication\u2014India, January 2010\u2013September 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2012.02.006_bib0105","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.1130388","article-title":"New strategies for the elimination of polio from India","volume":"314","author":"Grassly","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.coviro.2012.02.006_bib0110","first-page":"145","article-title":"Resurgence of wild poliovirus type 1 transmission and consequences of importation\u201421 countries, 2002\u20132005","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2012.02.006_bib0115","first-page":"1053","article-title":"Progress toward poliomyelitis eradication\u2014Nigeria, January 2010\u2013June 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2012.02.006_bib0120","first-page":"329","article-title":"Poliomyelitis 1980, Parts 1 and 2","volume":"56","author":"World Health Organization","year":"1981","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.coviro.2012.02.006_bib0125","first-page":"357","article-title":"Wild poliovirus type 1 and type 3 importations\u201415 countries, Africa, 2008\u20132009","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2012.02.006_bib0130_1","first-page":"1393","article-title":"Outbreaks following wild poliovirus importations\u2014Europe, Africa, and Asia, January 2009\u2013September 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2012.02.006_bib0135","first-page":"306","article-title":"Progress toward interrupting wild poliovirus circulation in countries with reestablished transmission\u2014Africa, 2009\u20132010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2012.02.006_bib0140","first-page":"312","article-title":"Notes from the field: Poliomyelitis outbreak\u2014Republic of the Congo, September 2010\u2013February 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2012.02.006_bib0145","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","article-title":"Vaccine-derived polioviruses and the endgame strategy for global polio eradication","volume":"59","author":"Kew","year":"2005","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.coviro.2012.02.006_bib0150","doi-asserted-by":"crossref","first-page":"e3433","DOI":"10.1371\/journal.pone.0003433","article-title":"Estimating the extent of vaccine-derived poliovirus infection","volume":"3","author":"Wringe","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coviro.2012.02.006_bib0155","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1086\/587694","article-title":"Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar","volume":"197","author":"Rakoto-Andrianarivelo","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2012.02.006_bib0160_1","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jiq140","article-title":"Outbreak of type 2 vaccine-derived poliovirus in Nigeria: 2005\u20132009: emergence and widespread circulation in an underimmunized population","volume":"203","author":"Wassilak","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2012.02.006_bib0165_1","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1056\/NEJMoa0910074","article-title":"Implications of a circulating vaccine-derived poliovirus in Nigeria","volume":"362","author":"Jenkins","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.coviro.2012.02.006_bib0170","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/infdis\/175.Supplement_1.S165","article-title":"Outbreaks of paralytic poliomyelitis, 1976\u20131995","volume":"175","author":"Patriarca","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2012.02.006_bib0175","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(07)60532-7","article-title":"Eradication versus control for poliomyelitis: an economic analysis","volume":"369","author":"Thompson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2012.02.006_bib0180","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1128\/JVI.77.16.8973-8984.2003","article-title":"Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the non-capsid coding region","volume":"77","author":"Brown","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2012.02.006_bib0185","first-page":"950","article-title":"Laboratory surveillance for wild and vaccine-derived polioviruses\u2014worldwide, January 2008\u2013June 2009","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2012.02.006_bib0190","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1128\/JCM.00702-09","article-title":"Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues","volume":"47","author":"Kilpatrick","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.coviro.2012.02.006_bib0195","first-page":"441","article-title":"Tracking progress toward global polio eradication\u2014worldwide, 2009\u20132010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2012.02.006_bib0200","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1128\/JVI.02354-07","article-title":"Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range","volume":"82","author":"Jorba","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2012.02.006_bib0205","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1128\/JVI.74.7.3001-3010.2000","article-title":"Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion","volume":"74","author":"Mart\u00edn","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2012.02.006_bib0210","doi-asserted-by":"crossref","first-page":"12623","DOI":"10.1128\/JVI.79.20.12623-12634.2005","article-title":"Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient","volume":"79","author":"Yang","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2012.02.006_bib0215","first-page":"1002","article-title":"Update on vaccine-derived polioviruses\u2014worldwide, January 2008\u2013June 2009","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2012.02.006_bib0220","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(04)16150-3","article-title":"Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man","volume":"363","author":"MacLennan","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.coviro.2012.02.006_bib0225_1","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1056\/NEJMoa1008677","article-title":"Vaccine-derived poliomyelitis 12 years after infection in Minnesota","volume":"364","author":"DeVries","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625712000338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625712000338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T07:58:33Z","timestamp":1543132713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625712000338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1879625712000338"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2012.02.006","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}